These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 10566728

  • 1. A double blind, randomized, placebo-controlled phase II study to assess the safety and efficacy of orally administered SP-303 for the symptomatic treatment of diarrhea in patients with AIDS.
    Holodniy M, Koch J, Mistal M, Schmidt JM, Khandwala A, Pennington JE, Porter SB.
    Am J Gastroenterol; 1999 Nov; 94(11):3267-73. PubMed ID: 10566728
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Albendazole chemotherapy for treatment of diarrhoea in patients with AIDS in Zambia: a randomised double blind controlled trial.
    Kelly P, Lungu F, Keane E, Baggaley R, Kazembe F, Pobee J, Farthing M.
    BMJ; 1996 May 11; 312(7040):1187-91. PubMed ID: 8634560
    [Abstract] [Full Text] [Related]

  • 5. Safety and efficacy of Virend for topical treatment of genital and anal herpes simplex lesions in patients with AIDS.
    Orozco-Topete R, Sierra-Madero J, Cano-Dominguez C, Kershenovich J, Ortiz-Pedroza G, Vazquez-Valls E, Garcia-Cosio C, Soria-Cordoba A, Armendariz AM, Teran-Toledo X, Romo-Garcia J, Fernandez H, Rozhon EJ.
    Antiviral Res; 1997 Jul 11; 35(2):91-103. PubMed ID: 9217246
    [Abstract] [Full Text] [Related]

  • 6. Randomized, double-blind, placebo-controlled clinical trial of loperamide plus simethicone versus loperamide alone and simethicone alone in the treatment of acute diarrhea with gas-related abdominal discomfort.
    Hanauer SB, DuPont HL, Cooper KM, Laudadio C.
    Curr Med Res Opin; 2007 May 11; 23(5):1033-43. PubMed ID: 17519069
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of crofelemer for noninfectious diarrhea in HIV-seropositive individuals (ADVENT trial): a randomized, double-blind, placebo-controlled, two-stage study.
    Macarthur RD, Hawkins TN, Brown SJ, Lamarca A, Clay PG, Barrett AC, Bortey E, Paterson C, Golden PL, Forbes WP.
    HIV Clin Trials; 2013 May 11; 14(6):261-73. PubMed ID: 24334179
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Multicenter trial of octreotide in patients with refractory acquired immunodeficiency syndrome-associated diarrhea.
    Simon DM, Cello JP, Valenzuela J, Levy R, Dickerson G, Goodgame R, Brown M, Lyche K, Fessel WJ, Grendell J.
    Gastroenterology; 1995 Jun 11; 108(6):1753-60. PubMed ID: 7768380
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of octreotide on refractory AIDS-associated diarrhea. A prospective, multicenter clinical trial.
    Cello JP, Grendell JH, Basuk P, Simon D, Weiss L, Wittner M, Rood RP, Wilcox CM, Forsmark CE, Read AE.
    Ann Intern Med; 1991 Nov 01; 115(9):705-10. PubMed ID: 1929038
    [Abstract] [Full Text] [Related]

  • 12. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A, Chua JV, Talwani R, Bentzen SM, Baddley J.
    Trials; 2020 Oct 28; 21(1):897. PubMed ID: 33115543
    [Abstract] [Full Text] [Related]

  • 13. Octreotide therapy of large-volume refractory AIDS-associated diarrhea: a randomized controlled trial.
    Garcia Compean D, Ramos Jimenez J, Guzman de la Garza F, Saenz C, Maldonado H, Barragan RF, Michel H.
    AIDS; 1994 Nov 28; 8(11):1563-7. PubMed ID: 7848592
    [Abstract] [Full Text] [Related]

  • 14. Oral diosmectite reduces stool output and diarrhea duration in children with acute watery diarrhea.
    Dupont C, Foo JL, Garnier P, Moore N, Mathiex-Fortunet H, Salazar-Lindo E, Peru and Malaysia Diosmectite Study Groups.
    Clin Gastroenterol Hepatol; 2009 Apr 28; 7(4):456-62. PubMed ID: 19268266
    [Abstract] [Full Text] [Related]

  • 15. Impact of protease inhibitors on the outcome of human immunodeficiency virus-infected patients with chronic diarrhea.
    Bini EJ, Cohen J.
    Am J Gastroenterol; 1999 Dec 28; 94(12):3553-9. PubMed ID: 10606318
    [Abstract] [Full Text] [Related]

  • 16. Multicenter, double-blind, randomized comparison of wood creosote, the principal active ingredient of Seirogan, an herbal antidiarrheal medication, and loperamide in adults with acute nonspecific diarrhea.
    Kuge T, Shibata T, Willett MS.
    Clin Ther; 2004 Oct 28; 26(10):1644-51. PubMed ID: 15598481
    [Abstract] [Full Text] [Related]

  • 17. [Controlled clinical testing of an antidiarrheal].
    Dorn M.
    MMW Fortschr Med; 2004 Aug 05; 146 Suppl 2():57-60. PubMed ID: 16739360
    [Abstract] [Full Text] [Related]

  • 18. Antimotility agents for chronic diarrhoea in people with HIV/AIDS.
    Nwachukwu CE, Okebe JU.
    Cochrane Database Syst Rev; 2008 Oct 08; (4):CD005644. PubMed ID: 18843696
    [Abstract] [Full Text] [Related]

  • 19. Evaluating the safety, tolerability, pharmacokinetics and efficacy of clofazimine in cryptosporidiosis (CRYPTOFAZ): study protocol for a randomized controlled trial.
    Nachipo P, Hermann D, Quinnan G, Gordon MA, Van Voorhis WC, Iroh Tam PY.
    Trials; 2018 Aug 23; 19(1):456. PubMed ID: 30139372
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study.
    Graff GR, Maguiness K, McNamara J, Morton R, Boyd D, Beckmann K, Bennett D.
    Clin Ther; 2010 Jan 23; 32(1):89-103. PubMed ID: 20171415
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.